FDA Approval of Psychedelics, Coming Soon?

A recent report from the Substance Abuse and Mental Health Services Administration (SAMHSA) encourages U.S. states to begin preparing for possible approval of psychedelic therapies by the Food and Drug Administration.

The transition from research to clinics is moving faster than those in the field anticipated even five years ago, the report notes, and being proactive is important.

“The question is not whether individuals in a particular state will use psychedelics, but whether they will do so in regulated, safe contexts or in underground networks,” the report reads.

Read more

Psychedelics and Science

Scientist Bruce Damer contends psychedelics hold potential for more than addressing the mental health crisis.

He is driven by the belief that psychedelic drugs can crack open the minds of scientists and other problem-solvers.

In 2023, he founded the nonprofit organization the Center for MINDS (Multidisciplinary Investigation into Novel Discoveries and Solutions). Its philosophy: “Psychedelics and other consciousness practices may be our greatest underutilized tool for sparking paradigm-shifting breakthroughs.”

Read more

Magic Mushrooms Without the Hallucinations

Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending side effects.

Researchers created modified versions of psilocin — the active form of psilocybin from “magic mushrooms” — that still target key serotonin pathways linked to depression and other brain disorders but appear to cause far fewer psychedelic-like effects.

Read more